Summary
This meta-analysis was carried out to evaluate the relationship between NM23 expression and the prognosis of patients with colorectal cancer. We searched PubMed, EMBASE and Web of Science for relevant articles. The pooled odd ratios (ORs) and corresponding 95%CI were calculated to evaluate the prognostic value of NM23 expression in patients with colorectal cancer, and the association between NM23 expression and clinicopathological factors. In total, 2289 patients were pooled from 24 available studies. The incorporative OR combined by 16 studies with overall survival showed that high NM23 expression was associated with better overall survival (OR=0.67, 95%CI: 0.49–0.93, P=0.02, I 2=56%, Ph=0.004). And a new estimate without heterogeneity was produced when only combining high-quality studies (OR=0.70, 95%CI: 0.56–0.86, P=0.0007, I 2=46%). In disease free survival (DFS), we also obtained a good prognosis (OR=0.30, 95%CI: 0.14–0.68, P=0.004). Although we failed to find any significance in N status (P=0.10), elevated NM23 expression was related to well tumor differentiation (OR=0.60, 95%CI: 0.44–0.820, P=0.001) and Dukes’ A&B (OR=0.55, 95%CI: 0.32–0.95, P=0.03). These results indicated that over-expressed NM23 might be an indicator of good prognosis, well tumor differentiation and Dukes’ A&B of patients with colorectal cancer, but no significance was found in N status.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin, 2015,65(1): 5–29
Ng L, Poon RT, Pang R. Biomarkers for predicting future metastasis of human gastrointestinal tumors. Cell Mol Life Sci, 2013,70(19): 3631–3656
Hari DM, Leung AM, Lee JH, et al. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg, 2013,217(2): 181–190
Jensen SL, Wood DP, Banks ER, et al. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate. World J Urol, 1996,14(Suppl 1):S21–25
Khan MH, Yasuda M, Higashino F, et al. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol, 2001,158(5): 1785–1791
Gao QL, Ma D, Meng L, et al. Association between Nm23-H1 gene expression and metastasis of ovarian carcinoma. Ai Zheng (Chinese), 2004,23(6): 650–654
Leone A, Flatow U, King CR, et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 1991,65(1): 25–35
Boissan M, de Wever O, Lizarraga F, et al. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res, 2010,70(19): 7710–7722
Kushlinskii NE, Yurchenko AA, Delektorskaya VV, et al. Relationship between expression of NM23 protein and clinical morphological factors and content of plasminogen activation system components in tumors of patients with gastric cancer. Bull Exp Biol Med, 2007,143(6): 733–736
Kim HJ, Kang HJ, Lee H, et al. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res, 2009,8(3): 1368–1379
Elagoz S, Egilmez R, Koyuncu A, et al. The intratumoral microvessel density and expression of bFGF and nm23-H1 in colorectal cancer. Pathol Oncol Res, 2006,12(1): 21–27
Youn BS, Kim DS, Kim JW, et al. NM23 as a prognostic biomarker in ovarian serous carcinoma. Modern Pathology, 2008,21(7): 885–892
Yang T, Chen BZ, Li DF, et al. Reduced NM23 protein level correlates with worse clinicopathologic features in colorectal cancers: a meta-analysis of pooled data. Medicine (Baltimore), 2016,95(4):pe2589
Han W, Ma J, Cao F, et al. Prognostic value of NM23 in patients with colorectal carcinoma: a systematic review and meta-analysis. PROSPERO, CRD42015029488.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010,25(9): 603–605
Wong WC, Cheung CS, Hart GJ. Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg Themes Epidemiol, 2008,5:23
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997,315(7109): 629–634
Garinis GA, Manolis EN, Spanakis NE, et al. High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas. J Mol Med, 2003,81(4): 256–263
Myeroff LL, Markowitz SD. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst, 1993,85(2): 147–152
Nobili S, Napoli C, Landini I, et al. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer. Int J Cancer, 2011,128(8): 1935–1945
Cohn KH, Ornstein DL, Wang FS, et al. The significance of allelic deletions and aneuploidy in colorectal carcinoma–Results of a 5-year follow-up study. Cancer, 1997,79(2): 233–244
Caligo MA, Ghimenti C, Sensi E, et al. Microsatellite alterations and K-ras, TGF beta RII, IGFRII and bax mutations in sporadic cancers of the gastrointestinal tract. Oncol Rep, 2000,7(6): 1371–1375
Cohn KH, Wang F, DeSoto-LaPaix F, et al. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet, 1991,338(8769): 722–724
Lamb RF, Going JJ, Pickford I, et al. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver. Cancer Res, 1996,56(4): 916–920
Leggett B, Young J, Buttenshaw R, et al. Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. Br J Cancer, 1995,71(5): 1070–1073
Berney CR, Fisher RJ, Yang JI, et al. Protein markers in colorectal cancer–Predictors of liver metastasis. Ann Surg, 1999,230(2): 179–184
Abad A, Ojanguren I, Font A, et al. Prognostic significance of the nm23-H1 protein expression in colorectal cancer. Eur J Cancer, 1996,32A(Suppl 1):S26–S26
Ayhan A, Yasui W, Yokozaki H, et al. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases inhuman colorectal carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol, 1993,63(4): 213–218
Berney CR, Yang JL, Fisher RJ, et al. Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival. World J Surg, 1998,22(5): 484–490
Bertucci F, Salas S, Eysteries S, et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene, 2004,23(7): 1377–1391
Cheah PY, Cao X, Eu KW, et al. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas. Br J Cancer, 1998,77(7): 1164–1168
Chen WC, Lin MS, Zhang BF, et al. Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray. World J Gastroenterol, 2007, 13(5): 699–708
Dursun A, Akyurek N, Gunel N, et al. Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology, 2002,34(5): 427–432
Heys SD, Langlois N, Smith IC, et al. NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer. Oncol Rep, 1998,5(3): 735–739
Ichikawa W. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer. Pathobiology, 1994,62(4): 172–179
Kapitanovic S, Cacev T, Berkovic M, et al. Nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol, 2004,57(12): 1312–1318
Lee JC, Lin YJ, Chow NH, et al. Reappraisal of the role of NM23-H1 in colorectal cancers. J Surg Oncol, 2001,76(1): 58–62
Lindmark G. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer, 1996,74(9): 1413–1418
Madbouly KM, Senagore AJ, Mukerjee A, et al. Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease? Int J Colorectal Dis, 2007,22(1): 39–48
Martinez J, Prevot S, Nordinger B, et al. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut, 1995, 37(5): 712–720
Messinetti S, Giacomelli L, Fabrizio G, et al. CD44v6 and Nm23-H1 protein expression related to clinico pathological parameters in colorectal cancer. Ann Ital Chir, 2003,74(1): 45–51
Oliveira LA, Artigiani-Neto R, Waisberg DR, et al. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival. Arq Gastroenterol, 2010,47(4), 361–367
Pasz-Walczak G, Salagacka A, Potemski P, et al. Maspin and Nm23-H1 expression in colorectal cancer. Neoplasma, 2010,57(2): 95–101
Su ZH, Li JC. Lymphatic metastasis and nm23H1 genetic instability in Chinese colon cancer patients. World J Gastroenterol, 2004,10(19): 2800–2804
Tabuchi Y, Nakamura T, Kuniyasu T, et al. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival. Surg Today, 1999,29(2): 116–120
Tannapfel A, Kockerling F, Katalinic A, et al. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum, 1995,38(6): 651–654
Tripkovic A, Tripkovic I, Tomic S, et al. The role of nm23 gene in colorectal carcinogenesis. Acta Clin Croat, 2012,51(1): 43–49
Wu HW, Gao LD, Wei GH. hMSH2 and nm23 expression in sporadic colorectal cancer and its clinical significance. Asian Pac J Cancer Prev, 2013,14(3): 1995–1998
Yamaguchi A, Urano T, Fushida S, et al. Inverse association of nm23-H1 expression by colorectal-cancer with liver metastasis. Br J Cancer, 1993,68(5): 1020–1024
Yang YQ, Wu L, Chen JX, et al. Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients. World J Gastroenterol, 2008,14(36): 5549–5556; discussion 5555
Lin XQ, Liang Y, Ding SP, et al. Genetic instability on chromosome 17q21 in gastric cancer of Chinese patients. Shi Yan Sheng Wu Xue Bao (Chinese), 2005,38(2): 148–156
Chen J, Zhou Q, Qin Y, et al. A study on the allelic deletion of nm23 genes in human lung cancer. Zhongguo Fei Ai Za Zhi, 2000,3(1): 8–13
Lu HY, Zhang GQ, Li JC. Study on genetic instability of nm23H1 gene in Chinese with original gallbladder tumor. Fen Zi Xi Bao Sheng Wu Xue Bao (Chinese), 2006,39(3): 249–257
Qin Z, Dai L, Toole B, et al. Regulation of Nm23-H1 and cell invasiveness by Kaposi’s sarcoma-associated herpesvirus. J Virol, 2011,85(7): 3596–3606
Marshall JC, Collins J, Marino N, et al. The Nm23-H1 metastasis suppressor as a translational target. Eur J Cancer, 2010,46(7): 1278–1282
Boissan M, Lacombe ML. Nm23/NDP kinases in hepatocellular carcinoma. J Bioenerg Biomembr, 2006,38(3-4): 169–175
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Han, W., Ma, J., Cao, F. et al. The role of NM23 in patients with colorectal cancer: A systematic review and meta-analysis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 37, 1–10 (2017). https://doi.org/10.1007/s11596-017-1686-z
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-017-1686-z